White Blood Cell-Boosting Drugs Investigated By FDA As Treatments For Nuclear Radiation Exposure
Category: WELLNESS
She declined to comment on whether Amgen planned to participate in any future trials of Neupogen or Neulasta as treatments
By Reuters, Reuters, 2013-05-01